Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine whether Enhanced device programming to reduce therapies (i.e. anti tachycardia pacing (ATP) episodes and shocks (both appropriate and inappropriate)) is safe for patients implanted with an Implantable Cardioverter-Defibrillator (ICD). The secondary objective is to examine the impact of Enhanced programming on (i) ATPs and shocks (both appropriate and inappropriate) and (ii) quality of life and distress.


Clinical Trial Description

ICD therapy has become the first-line treatment for the prevention of sudden cardiac death both as primary and secondary prevention due to its proven survival benefits as compared to anti-arrhythmic drugs. However, ICD therapy is associated with a number of complications and shocks that may impair patient quality of life and well being but also influence mortality. Hence, reduction of ICD shocks by means of alternative programming of the device is paramount for improving patient-centered outcomes and mortality.

The ENHANCED-ICD study will be a prospective, single-arm safety monitoring study. All patients will receive Enhanced programming. Furthermore, patients will be asked to complete a set of standardized and validated self-report questionnaires prior to ICD implantation, at 3-, 6-, and 12 months post implantation. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01715116
Study type Interventional
Source UMC Utrecht
Contact Mathias Meine, MD, PhD
Phone +31(0)884666184
Email m.meine@umcutrecht.nl
Status Unknown status
Phase N/A
Start date April 2013
Completion date April 2016

See also
  Status Clinical Trial Phase
Recruiting NCT05175937 - REal World Assessment for Patients Implanted With Implantable CardioverTer DefibrIllatOr Using Bluetooth Technology
Not yet recruiting NCT05005143 - Improved Procedural Workflow For Catheter Ablation Of Paroxysmal AF With High Density Mapping System And Advanced Technology
Completed NCT02684825 - Detection of Silent Atrial Fibrillation aFter Ischemic StrOke N/A
Terminated NCT01936480 - Genetics of QT Response to Moxifloxacin Phase 4
Completed NCT01719978 - Hemodynamic and Electrocardiographic Effects of Hyaluronidase Associated With Local Anaesthetics Phase 4
Completed NCT00418314 - FREEDOM - A Frequent Optimization Study Using the QuickOpt Method N/A
Completed NCT04361006 - Cryotherapy Versus Radiofrequency Ablation for Treatment of Para-hisian Accessory Pathways N/A
Completed NCT02326519 - Electrical Signal Collection From a 20 Pole Catheter During Routine Cardiac Procedures N/A
Completed NCT01642537 - Electroanatomical Mapping of Patients Undergoing Catheter Ablation Procedures Using Rhythmia Mapping System and Catheter N/A
Completed NCT01509378 - 4P Study: Predictive Quality With Painfree Therapies N/A
Completed NCT02698670 - Prospective Registry on User Experience With The Mapping System For Ablation Procedures N/A
Recruiting NCT01566344 - Reversal of Cardiomyopathy by Suppression of Frequent Premature Ventricular Complexes N/A
Recruiting NCT03793998 - Catheter Ablation of Arrhythmias With High Density Mapping System in the Real World Practice.
Active, not recruiting NCT03110627 - Increasing Detection of Sub-Clinical Atrial Fibrillation in Defibrillator Patients With the Use of a VDD-ICD Lead N/A
Recruiting NCT05771142 - Evaluation of an Innovative Smart T-shirt Capable to Monitor ECG Signal and Related Parameters Through the Comparison With a Holter ECG and a Smartwatch
Not yet recruiting NCT02657590 - Documentation of Cardiac Arrhythmias After Open Heart Surgery N/A
Completed NCT02080975 - Determination of Catheter Contact by Evaluation of Microelectrode Near-Field Signals N/A
Recruiting NCT05724121 - Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
Completed NCT02332096 - Screening for Sleep Apnea in Patients Undergoing Atrial Fibrillation Ablation
Completed NCT01946776 - Cardiac Arrhythmias in Epilepsy: the CARELINK-study N/A